An ergot-derived dopamine receptor agonist used to treat Parkinson’s disease.
May induce fibrosis of valve leaflets and in the mitral subvalvular apparatus with thickening, stiffening and retracting of valves with incomplete leaflet coaptation and valve regurgitation.